» Articles » PMID: 28534077

White Matter Injury in the Preterm Infant: Pathology and Mechanisms

Overview
Specialty Neurology
Date 2017 May 24
PMID 28534077
Citations 196
Authors
Affiliations
Soon will be listed here.
Abstract

The human preterm brain is particularly susceptible to cerebral white matter injury (WMI) that disrupts the normal progression of developmental myelination. Advances in the care of preterm infants have resulted in a sustained reduction in the severity of WMI that has shifted from more severe focal necrotic lesions to milder diffuse WMI. Nevertheless, WMI remains a global health problem and the most common cause of chronic neurological morbidity from cerebral palsy and diverse neurobehavioral disabilities. Diffuse WMI involves maturation-dependent vulnerability of the oligodendrocyte (OL) lineage with selective degeneration of late oligodendrocyte progenitors (preOLs) triggered by oxidative stress and other insults. The magnitude and distribution of diffuse WMI are related to both the timing of appearance and regional distribution of susceptible preOLs. Diffuse WMI disrupts the normal progression of OL lineage maturation and myelination through aberrant mechanisms of regeneration and repair. PreOL degeneration is accompanied by early robust proliferation of OL progenitors that regenerate and augment the preOL pool available to generate myelinating OLs. However, newly generated preOLs fail to differentiate and initiate myelination along their normal developmental trajectory despite the presence of numerous intact-appearing axons. Disrupted preOL maturation is accompanied by diffuse gliosis and disturbances in the composition of the extracellular matrix and is mediated in part by inhibitory factors derived from reactive astrocytes. Signaling pathways implicated in disrupted myelination include those mediated by Notch, WNT-beta catenin, and hyaluronan. Hence, there exists a potentially broad but still poorly defined developmental window for interventions to promote white matter repair and myelination and potentially reverses the widespread disturbances in cerebral gray matter growth that accompanies WMI.

Citing Articles

Targeting Neuroinflammation in Preterm White Matter Injury: Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes.

Zhang X, Zhang Y, Peng X, Yang L, Miao J, Yue Y Cell Mol Neurobiol. 2025; 45(1):23.

PMID: 40072734 PMC: 11903990. DOI: 10.1007/s10571-025-01540-6.


Brain and Serum Membrane Vesicle (Exosome) Profiles in Experimental Alcohol-Related Brain Degeneration: Forging the Path to Non-Invasive Liquid Biopsy Diagnostics.

de la Monte S, Yang Y, Tong M J Mol Pathol (Basel). 2025; 5(3):360-384.

PMID: 39931524 PMC: 11810071. DOI: 10.3390/jmp5030025.


White Matter Injury in Central Nervous System Disorders.

Zheng L, Wang X, Li P, Hao Y, Zhang H, Chen H Neuropsychiatr Dis Treat. 2025; 21:107-114.

PMID: 39877856 PMC: 11774249. DOI: 10.2147/NDT.S498660.


The roles of pleiotrophin in brain injuries: a narrative review of the literature.

Lei Y, Zhou R, Mao Q, Qiu X, Mu D Ann Med. 2025; 57(1):2452353.

PMID: 39829367 PMC: 11749013. DOI: 10.1080/07853890.2025.2452353.


Neonatal inflammation and near-term white matter microstructure in infants born very preterm.

Anderson K, Lazarus M, Bruckert L, Poblaciones R, Scala M, Marchman V Neuroimage Rep. 2025; 4(4.

PMID: 39822573 PMC: 11737600. DOI: 10.1016/j.ynirp.2024.100226.


References
1.
Delobel-Ayoub M, Arnaud C, White-Koning M, Casper C, Pierrat V, Garel M . Behavioral problems and cognitive performance at 5 years of age after very preterm birth: the EPIPAGE Study. Pediatrics. 2009; 123(6):1485-92. DOI: 10.1542/peds.2008-1216. View

2.
Marret S, Mukendi R, Gadisseux J, Gressens P, Evrard P . Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol. 1995; 54(3):358-70. DOI: 10.1097/00005072-199505000-00009. View

3.
Riddle A, Maire J, Cai V, Nguyen T, Gong X, Hansen K . Hemodynamic and metabolic correlates of perinatal white matter injury severity. PLoS One. 2014; 8(12):e82940. PMC: 3886849. DOI: 10.1371/journal.pone.0082940. View

4.
Bax M, Tydeman C, Flodmark O . Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study. JAMA. 2006; 296(13):1602-8. DOI: 10.1001/jama.296.13.1602. View

5.
Billiards S, Haynes R, Folkerth R, Borenstein N, Trachtenberg F, Rowitch D . Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol. 2008; 18(2):153-63. PMC: 2770329. DOI: 10.1111/j.1750-3639.2007.00107.x. View